Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 28, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.9K

HDL-Mediated Cellular Cholesterol Efflux Assay Method.

Anouar Hafiane1, Jacques Genest2

  • 1Cardiovascular Research Laboratories, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada anouar.hafiane@mail.mcgill.ca anouarhafiane@yahoo.com.

Annals of Clinical and Laboratory Science
|December 15, 2015
PubMed
Summary

This study presents a simplified, scalable cholesterol efflux assay to measure high-density lipoprotein (HDL) function. The optimized method improves accuracy for cardiovascular risk assessment in research and drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Atherosclerosis·2026
Same author

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

European journal of preventive cardiology·2026
Same author

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Atherosclerosis·2026
Same author

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

JACC. Advances·2026
Same author

Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration.

Atherosclerosis·2025
Same author

Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia.

European journal of medical research·2025

Area of Science:

  • Biochemistry
  • Cardiovascular Research
  • Cell Biology

Background:

  • High-density lipoprotein (HDL) function biomarkers offer superior cardiovascular risk assessment compared to HDL-cholesterol levels.
  • Standardized, high-throughput assays are needed to accurately measure HDL function, specifically cholesterol efflux.
  • Existing assays face challenges in accuracy and reproducibility due to various influencing factors.

Purpose of the Study:

  • To describe a simplified, medium-throughput experimental protocol for determining cholesterol efflux from cultured macrophages.
  • To standardize and optimize the cellular cholesterol efflux assay for improved accuracy and scalability.
  • To address critical factors affecting assay performance, ensuring reliable results.

Main Methods:

Keywords:
ABCA1Apolipoprotein A-ICholesterol effluxHDLReverse cholesterol transportpolyethylene glycol

More Related Videos

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

537

Related Experiment Videos

Last Updated: Mar 28, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.9K
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

537
  • Development of a multi-step, cell-based assay to quantify cholesterol efflux to acceptor particles or plasma.
  • Optimization of the polyethylene glycol (PEG) precipitation method by including an additional centrifugation step for HDL fractions.
  • Evaluation of PEG's effect on cholesterol efflux efficiency using plasma and serum.

    • Main Results:

    • An optimized protocol for measuring cholesterol efflux from macrophages was established.
    • Further centrifugation of HDL fractions effectively prevents apolipoprotein B contamination when using the PEG method.
    • Polyethylene glycol (PEG) demonstrated no adverse effect on cholesterol efflux efficiency in plasma or serum.

    Conclusions:

    • The described simplified cholesterol efflux assay is accurate, reproducible, and scalable for medium-throughput analysis.
    • This optimized method enhances the utility of HDL function as a biomarker in cardiovascular research and drug efficacy studies.
    • The protocol provides a reliable tool for investigating cardiovascular disease mechanisms and evaluating pharmacologic therapies.